Cardiomyopathy Due to AnthracyclinesSymptoms, Doctors, Treatments, Advances & More
Cardiomyopathy Due to Anthracyclines Overview
Learn About Cardiomyopathy Due to Anthracyclines
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Beth Israel Deaconess HealthCare - Medical Care Ctr Lexington
Aarti Asnani is a primary care provider, practicing in Internal Medicine in Lexington, Massachusetts. She has been practicing medicine for over 18 years. Dr. Asnani is rated as an Elite provider by MediFind in the treatment of Cardiomyopathy Due to Anthracyclines. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Doxorubicin-Induced Cardiomyopathy, Cardiomyopathy Due to Anthracyclines, Myocarditis, Cardiomyopathy, and Pacemaker Implantation. Dr. Asnani is board certified in American Board Of Internal Medicine. Dr. Asnani is currently accepting new patients.
Brigham And Women's Hospital, Heart And Vascular Center
Anju Nohria is a Cardiologist practicing medicine in Boston, Massachusetts. Dr. Nohria is rated as an Elite provider by MediFind in the treatment of Cardiomyopathy Due to Anthracyclines. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Myocarditis, Cardiomyopathy Due to Anthracyclines, Cardiomyopathy, Cardiac Ablation, and Heart Transplant. Dr. Nohria is board certified in Advanced Heart Failure And Transplant Cardiology and Cardiovascular Disease. Dr. Nohria is currently accepting new patients.
Pawan Singal practices practicing medicine in Winnipeg, Canada. Mr. Singal is rated as an Elite expert by MediFind in the treatment of Cardiomyopathy Due to Anthracyclines. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Doxorubicin-Induced Cardiomyopathy, Cardiomyopathy Due to Anthracyclines, Cardiomyopathy, and Heart Failure.
Summary: This is a randomized controlled clinical trial that aims to evaluate the safety and efficacy of Dapagliflozin as a cardioprotective in doxorubicin-induced cardiotoxicity in breast cancer patients.
Summary: Patients treated for DLBCL are at high risk of developing AICD. This adverse event is characterized by irreversible damage to the heart muscle with a loss of cardiomyocytes and subsequent decline in cardiac pumping capacity. Thereby patients treated for this malignancy are at double the risk of developing symptomatic heart failure / cardiomyopathy when compared to the general population. This corr...

